KADCYLA 160


Powder for concentrate for solution for infusion
scheduling status
S4
registration number
49/32.16/0198
What KADCYLA 160 contains
trastuzumab emtansine.
other ingredients
Polysorbate 20, Sodium hydroxide, Succinic acid, Sucrose.
Therapeutic classification
L01XC14.
© 2026 SAHPRA. ALL RIGHTS RESERVED